Effets de la perte de poids sur la morbidité et la mortalité cardiovasculaires des diabétiques de type 2

Guh, 2009, The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis, BMC Public Health, 9, 88, 10.1186/1471-2458-9-88 Bogers, 2007, Association of overweight with increased risk of coronary heart disease partly independent of blood pressure and cholesterol levels: a meta-analysis of 21 cohort studies including more than 300 000 persons, Arch Intern Med., 167, 1720, 10.1001/archinte.167.16.1720 Jonsson, 2002, Influence of obesity on cardiovascular risk. Twenty-three-year follow-up of 22,025 men from an urban Swedish population, Int J Obes Relat Metab Disord., 26, 1046, 10.1038/sj.ijo.0802060 Williamson, 2000, Intentional weight loss and mortality among overweight individuals with diabetes, Diabetes Care., 23, 1499, 10.2337/diacare.23.10.1499 Franco, 2013, Population-wide weight loss and regain in relation to diabetes burden and cardiovascular mortality in Cuba 1980–2010: repeated cross sectional surveys and ecological comparison of secular trends, BMJ, 346, f1515, 10.1136/bmj.f1515 American Diabetes Association, 2013, Standards of medical care in diabetes-2013, Diabetes Care, 36, S11, 10.2337/dc13-S011 Holman, 2008, 10-year follow-up of intensive glucose control in type 2 diabetes, N Engl J Med., 359, 1577, 10.1056/NEJMoa0806470 Doehner, 2012, Inverse relation of body weight and weight change with mortality and morbidity in patients with type 2 diabetes and cardiovascular co-morbidity: an analysis of the PROactive study population, Int J Cardiol., 162, 20, 10.1016/j.ijcard.2011.09.039 James, 2010, Effect of sibutramine on cardiovascular outcomes in overweight and obese subjects, N Engl J Med., 363, 905, 10.1056/NEJMoa1003114 Gerstein, 2008, Effects of intensive glucose lowering in type 2 diabetes, N Engl J Med., 358, 2545, 10.1056/NEJMoa0802743 Wing, 2013, Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes, N Engl J Med., 369, 145, 10.1056/NEJMoa1212914 2012, National Institutes of Health Estruch, 2013, Primary prevention of cardiovascular disease with a Mediterranean diet, N Engl J Med., 368, 1279, 10.1056/NEJMoa1200303 Gong, 2011, Long-term effects of a randomised trial of a 6-year lifestyle intervention in impaired glucose tolerance on diabetes-related microvascular complications: the China Da Qing Diabetes Prevention Outcome Study, Diabetologia, 54, 300, 10.1007/s00125-010-1948-9 Lindstrom, 2003, The Finnish Diabetes Prevention Study (DPS): Lifestyle intervention and 3-year results on diet and physical activity, Diabetes Care., 26, 3230, 10.2337/diacare.26.12.3230 Foster, 2009, A randomized study on the effect of weight loss on obstructive sleep apnea among obese patients with type 2 diabetes: the Sleep AHEAD study, Arch Intern Med., 169, 1619, 10.1001/archinternmed.2009.266 Faulconbridge, 2012, One-year changes in symptoms of depression and weight in overweight/obese individuals with type 2 diabetes in the Look AHEAD study, Obesity (Silver Spring), 20, 783, 10.1038/oby.2011.315 Rubin, 2014, Impact of intensive lifestyle intervention on depression and health-related quality of life in type 2 diabetes: the Look AHEAD Trial, Diabetes Care, 37, 1544, 10.2337/dc13-1928 Phelan, 2012, Weight loss prevents urinary incontinence in women with type 2 diabetes: results from the Look AHEAD trial, J Urol., 187, 939, 10.1016/j.juro.2011.10.139 Breyer, 2014, Intensive lifestyle intervention reduces urinary incontinence in overweight/obese men with type 2 diabetes: results from the Look AHEAD trial, J Urol., 192, 144, 10.1016/j.juro.2014.02.036 Williamson, 2009, Impact of a weight management program on health-related quality of life in overweight adults with type 2 diabetes, Arch Intern Med., 169, 163, 10.1001/archinternmed.2008.544 Foy, 2011, Intensive lifestyle intervention improves physical function among obese adults with knee pain: findings from the Look AHEAD trial, Obesity (Silver Spring)., 19, 83, 10.1038/oby.2010.120 Romeo, 2012, Cardiovascular events after bariatric surgery in obese subjects with type 2 diabetes, Diabetes Care, 35, 2613, 10.2337/dc12-0193 Scheen, 2006, Efficacy and tolerability of rimonabant in overweight or obese patients with type 2 diabetes: a randomised controlled study, Lancet., 368, 1660, 10.1016/S0140-6736(06)69571-8 McNulty, 2003, A randomized trial of sibutramine in the management of obese type 2 diabetic patients treated with metformin, Diabetes Care., 26, 125, 10.2337/diacare.26.1.125 Garber, 2009, Liraglutide versus glimepiride monotherapy for type 2 diabetes (LEAD-3 Mono): a randomised, 52-week, phase III, double-blind, parallel-treatment trial, Lancet., 373, 473, 10.1016/S0140-6736(08)61246-5 Schauer, 2014, Bariatric surgery versus intensive medical therapy for diabetes-3-year outcomes, N Engl J Med., 370, 2002, 10.1056/NEJMoa1401329 Sun, 2015, Effect of glucagon-like peptide-1 receptor agonists on lipid profiles among type 2 diabetes: a systematic review and network meta-analysis, Clin Ther., 37, 225, 10.1016/j.clinthera.2014.11.008 Ikramuddin, 2013, Roux-en-Y gastric bypass vs intensive medical management for the control of type 2 diabetes, hypertension, and hyperlipidemia: the Diabetes Surgery Study randomized clinical trial, Jama., 309, 2240, 10.1001/jama.2013.5835 Mingrone, 2012, Bariatric surgery versus conventional medical therapy for type 2 diabetes, N Engl J Med., 366, 1577, 10.1056/NEJMoa1200111